⌘K
Loading ticker…
As of 2026-08-24, Citius Oncology, Inc. Common Stock (CTOR) has a 3-month relative strength percentile of 29 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 10.9%, relative volume 0.13×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CTOR is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $229K notional.
Held by 2 ETFs · $332K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $229K | — |
| VXFVanguard Extended Market ETF | 0.00% | $102K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CTOR Jan avg: 5.22% median: 5.22% win: 100% σ: 1.11% n: 2 2024-08-14 → 2026-07-31 | CTOR Feb avg: 2.37% median: 2.37% win: 50% σ: 4.65% n: 2 2024-08-14 → 2026-07-31 | CTOR Mar avg: -33.25% median: -33.25% win: 0% σ: 16.12% n: 2 2024-08-14 → 2026-07-31 | CTOR Apr avg: 17.65% median: 17.65% win: 50% σ: 34.36% n: 2 2024-08-14 → 2026-07-31 | CTOR May avg: -2.82% median: -2.82% win: 50% σ: 9.17% n: 2 2024-08-14 → 2026-07-31 | CTOR Jun avg: 182.40% median: 182.40% win: 50% σ: 284.16% n: 2 2024-08-14 → 2026-07-31 | CTOR Jul avg: -29.04% median: -29.04% win: 0% σ: 28.50% n: 2 2024-08-14 → 2026-07-31 | CTOR Aug avg: -23.25% median: -23.25% win: 0% σ: 30.32% n: 2 2024-08-14 → 2026-07-31 (current) | CTOR Sep avg: -13.96% median: -13.96% win: 0% σ: 10.62% n: 2 2024-08-14 → 2026-07-31 | CTOR Oct avg: -14.27% median: -14.27% win: 0% σ: 0.68% n: 2 2024-08-14 → 2026-07-31 | CTOR Nov avg: -22.08% median: -22.08% win: 0% σ: 0.51% n: 2 2024-08-14 → 2026-07-31 | CTOR Dec avg: -0.94% median: -0.94% win: 50% σ: 36.86% n: 2 2024-08-14 → 2026-07-31 |